📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Genetesis

1.1 - Company Overview

Genetesis Logo

Genetesis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medical imaging leveraging data science and biomagnetism for cardiovascular disease, offering CardioFlux, a non-invasive cardiac imaging system that measures the magnetic fields generated by the heart's electrical activity to assess myocardial ischemia and microvascular function, and the MAGNETO Trial, a multicenter, prospective, observational cohort study evaluating the diagnostic performance of MCG versus standard noninvasive stress testing in emergency department patients.

Products and services

  • MAGNETO Trial: A multicenter, prospective, observational cohort study evaluating the diagnostic performance of MCG compared to standard noninvasive stress testing for detecting myocardial ischemia in emergency department patients
  • CardioFlux: A non-invasive cardiac imaging system measuring magnetic fields generated by the heart’s electrical activity to assess myocardial ischemia and microvascular function, clinical-grade

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Genetesis

Contego Medical Logo

Contego Medical

HQ: United States Website
  • Description: Provider of novel embolic protection devices and integrated vascular intervention systems, including Paladin IEP carotid PTA balloons for protected stenting; Neuroguard IEP carotid stent and post-dilation systems; Excipio dual-mode thrombectomy devices with physician-controlled expandable baskets; and Vanguard IEP peripheral angioplasty balloons with integrated embolic protection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Contego Medical company profile →
Hemosphere Logo

Hemosphere

HQ: United States Website
  • Description: Provider of proprietary graft-based vascular access solutions for dialysis, marketing the HeRO (Hemodialysis Reliable Outflow) Graft, a fully subcutaneous arteriovenous access solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction, designed to maintain long-term access without venous anastomosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hemosphere company profile →
InnAVasc Logo

InnAVasc

HQ: United States Website
  • Description: Provider of medical devices for vascular access in hemodialysis, focusing on immediate access, home hemodialysis, and dialysis needle protection; offering the InnAVasc Graft with protective backplates and self-sealing materials to prevent needle injuries and bleeding complications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InnAVasc company profile →
LifeLens Technologies Logo

LifeLens Technologies

HQ: United States Website
  • Description: Provider of wearable personal health monitoring solutions, including the LifeLens Wireless ECG Monitor for adults with symptoms such as palpitations or dizziness; wearable physiological sensors for the U.S. Military to monitor health, readiness, and performance in real time; and an AI-enabled real-time physiological monitoring system for remote and in-hospital assessment of health readiness and performance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LifeLens Technologies company profile →
Silvergate Pharmaceuticals Logo

Silvergate Pharmaceuticals

HQ: United States Website
  • Description: Provider of pediatric medications, developing and commercializing innovative oral solutions that improve dosing accuracy, safety, and availability. Products include Xatmep (methotrexate) for pediatric acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis; Qbrelis (lisinopril) for hypertension (adults/pediatric 6+), adjunct heart failure, and acute MI in adults; and EPANED (enalapril) for hypertension (adults/pediatric >1 month), symptomatic heart failure, and asymptomatic left ventricular dysfunction.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Silvergate Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Genetesis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Genetesis

2.2 - Growth funds investing in similar companies to Genetesis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Genetesis

4.2 - Public trading comparable groups for Genetesis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Genetesis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Genetesis

What does Genetesis do?

Genetesis is a provider of medical imaging leveraging data science and biomagnetism for cardiovascular disease, offering CardioFlux, a non-invasive cardiac imaging system that measures the magnetic fields generated by the heart's electrical activity to assess myocardial ischemia and microvascular function, and the MAGNETO Trial, a multicenter, prospective, observational cohort study evaluating the diagnostic performance of MCG versus standard noninvasive stress testing in emergency department patients.

Who are Genetesis's competitors?

Genetesis's competitors and similar companies include Contego Medical, Hemosphere, InnAVasc, LifeLens Technologies, and Silvergate Pharmaceuticals.

Where is Genetesis headquartered?

Genetesis is headquartered in United States.

How many employees does Genetesis have?

Genetesis has 1,000 employees 🔒.

When was Genetesis founded?

Genetesis was founded in 2010 🔒.

What sector and industry vertical is Genetesis in?

Genetesis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Genetesis

Who are the top strategic acquirers in Genetesis's sector and industry

Top strategic M&A buyers and acquirers in Genetesis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Genetesis?

Top strategic M&A buyers groups and sectors for Genetesis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Genetesis's sector and industry vertical

Which are the top PE firms investing in Genetesis's sector and industry vertical?

Top PE firms investing in Genetesis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Genetesis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Genetesis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Genetesis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Genetesis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Genetesis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Genetesis?

The key public trading comparables and valuation benchmarks for Genetesis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Genetesis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Genetesis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Genetesis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Genetesis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Genetesis's' sector and industry vertical?

Access recent funding rounds and capital raises in Genetesis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Genetesis